Harvey W R, Monk C R
Bristol Royal Infirmary, United Kingdom.
Anaesth Intensive Care. 1995 Dec;23(6):673-7. doi: 10.1177/0310057X9502300602.
We conducted a randomized, double-blind investigation to determine whether enoximone affects the actions of dobutamine in patients taking beta adrenoceptor antagonists. We studied sixteen patients with good ventricular function after coronary artery bypass operations. All patients were taking a beta adrenoceptor antagonist. The patients received a standardized intravenous anaesthetic, which was maintained throughout the investigation. They received a masked infusion, containing either normal saline or enoximone. Haemodynamic data were recorded before, during, and after an infusion of dobutamine, which was given at three different rates. Patients receiving enoximone had a greater cardiac output, a higher heart rate and a lower systemic vascular resistance than patients receiving saline. They also required an average of 1500 ml more intravenous colloid in the immediate postoperative period to achieve haemodynamic stability. Dobutamine produced a consistent, significant peripheral vasoconstriction, but no inotropic or chronotropic effect. There was no significant difference in this effect between the two groups, and it was not influenced by concurrent therapy with enoximone. The alpha adrenergic action of dobutamine prevented us from using high enough rates of infusion to explore any interaction between the inotropic actions of dobutamine and enoximone.
我们进行了一项随机双盲研究,以确定依诺昔酮对服用β肾上腺素能受体拮抗剂患者中多巴酚丁胺作用的影响。我们研究了16例冠状动脉搭桥术后心室功能良好的患者。所有患者均服用β肾上腺素能受体拮抗剂。患者接受标准化静脉麻醉,并在整个研究过程中维持。他们接受了一种盲法输注,其中含有生理盐水或依诺昔酮。在以三种不同速率输注多巴酚丁胺之前、期间和之后记录血流动力学数据。接受依诺昔酮的患者比接受生理盐水的患者心输出量更大、心率更高且全身血管阻力更低。他们在术后即刻还平均需要多1500毫升静脉胶体来实现血流动力学稳定。多巴酚丁胺产生了持续且显著的外周血管收缩,但没有变力或变时作用。两组之间在这种作用上没有显著差异,并且不受与依诺昔酮联合治疗的影响。多巴酚丁胺的α肾上腺素能作用使我们无法使用足够高的输注速率来探究多巴酚丁胺和依诺昔酮变力作用之间的任何相互作用。